Review

CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects

Number: 2026-1 November 15, 2026

CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects

Abstract

Carbapenemase-producing Gram-negative bacteria require rapid detection of resistance determinants to support clinical microbiology and infection-control decisions. CRISPR/Cas12a biosensors offer sequence-specific recognition coupled with collateral cleavage of single-stranded DNA reporters, enabling fluorescence and lateral-flow detection. This focused narrative review examines 11 representative primary studies published between 2020 and 2026, comparing amplification strategies, analytical sensitivity, validation materials, assay configurations, and point-of-care potential. Most platforms target blaKPC and blaNDM, with more limited coverage of blaOXA-48-like, blaVIM, and blaIMP. Reported analytical detection limits vary substantially across purified DNA, cultured isolates, and spiked matrices, limiting direct comparison. Although selected studies report high agreement with molecular reference methods, clinical validation frequently involves small, predefined populations. Recent closed-tube and one-pot configurations reduce handling requirements, but complete sample-to-answer performance remains inconsistently evaluated. Further prospective validation using representative patient specimens, broader gene coverage, internal controls, and standardized reporting is required before routine clinical implementation.

Keywords

CRISPR/Cas12a, Biosensor, Antimicrobial resistance, Carbapenem resistance, Carbapenemase genes, - Point-of-care diagnostics

Supporting Institution

No external funding or institutional financial support was received for this study.

Ethical Statement

Ethical approval was not required because this article is a review of previously published literature and did not involve human participants, animals, or the collection of new data.

Thanks

The author has no acknowledgments to declare.

References

  1. World Health Organization. (2024). WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization. ISBN 978-92-4-009346-1. https://www.who.int/publications/i/item/9789240093461
  2. Antimicrobial Resistance Collaborators. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
  3. Kumar, M., Bhalla, G. S., Tandel, K., Jain, S., Singh, G., Mahajan, P., Shergill, S. P. S., & Gupta, R. M. (2024). Phenotypic and molecular methods of carbapenemase detection: Can we break the chain and preserve the carbapenems? Medical Journal Armed Forces India, 80(6), 657–666. https://doi.org/10.1016/j.mjafi.2023.05.008
  4. Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018). CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 360(6387), 436–439. https://doi.org/10.1126/science.aar6245
  5. Du, K., Zeng, Q., Jiang, M., Hu, Z., Zhou, M., & Xia, K. (2025). CRISPR/Cas12a-Based Biosensing: Advances in Mechanisms and Applications for Nucleic Acid Detection. Biosensors, 15(6), 360. https://doi.org/10.3390/bios15060360
  6. Curti, L. A., Pereyra-Bonnet, F., Repizo, G. D., Fay, J. V., Salvatierra, K., Blariza, M. J., Ibañez-Alegre, D., Rinflerch, A. R., Miretti, M., & Gimenez, C. A. (2020). CRISPR-based platform for carbapenemases and emerging viruses detection using Cas12a (Cpf1) effector nuclease. Emerging Microbes & Infections, 9(1), 1140–1148. https://doi.org/10.1080/22221751.2020.1763857
  7. Shin, J., Kim, S. R., Xie, Z., Jin, Y.-S., & Wang, Y.-C. (2024). A CRISPR/Cas12a-Based System for Sensitive Detection of Antimicrobial-Resistant Genes in Carbapenem-Resistant Enterobacterales. Biosensors, 14(4), 194. https://doi.org/10.3390/bios14040194
  8. Li, K., Wu, Y., Liu, M., Yan, J., & Wei, L. (2024). Cas12a/Guide RNA-Based Platform for Rapidly and Accurately Detecting blaKPC Gene in Carbapenem-Resistant Enterobacterales. Infection and Drug Resistance, 17, 2451–2462. https://doi.org/10.2147/IDR.S462088
  9. Yang, J. W., Kim, H., Hyeon, L.-S., Yoo, J. S., & Kang, S. (2024). Development of a Recombinase Polymerase Amplification-Coupled CRISPR/Cas12a Platform for Rapid Detection of Antimicrobial-Resistant Genes in Carbapenem-Resistant Enterobacterales. Biosensors, 14(11), 536. https://doi.org/10.3390/bios14110536
  10. Patil, S., Siji, A., Mallur, D., Kruthika, B. S., Gheewalla, N., Karve, S., Kavathekar, M., Tarai, B., Naik, M., Hegde, V., Rangineni, J., Gupta, V., Chandru, V., Pradeep, B. E., & Arora, R. (2025). PathCrisp: An innovative molecular diagnostic tool for early detection of NDM-resistant infections. Scientific Reports, 15, 490. https://doi.org/10.1038/s41598-024-84832-z
APA
Adil, M. M. (2026). CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects. Turkish Journal of Sensors and Biosensors, 2026-1, 1-12. https://izlik.org/JA66CZ85NZ
AMA
1.Adil MM. CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects. Turkish Journal of Sensors and Biosensors. 2026;(2026-1):1-12. https://izlik.org/JA66CZ85NZ
Chicago
Adil, Mir Muhammad. 2026. “CRISPR/Cas12a-Based/Biosensors/for/Rapid/Detection/of/Carbapenem/Resistance/Genes:/Recent/Advances/and/Point-of-Care/Prospects”. Turkish Journal of Sensors and Biosensors, no. 2026-1: 1-12. https://izlik.org/JA66CZ85NZ.
EndNote
Adil MM (November 15, 2026) CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects. Turkish Journal of Sensors and Biosensors 2026-1 1–12.
IEEE
[1]M. M. Adil, “CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects”, Turkish Journal of Sensors and Biosensors, no. 2026-1, pp. 1–12, Nov. 2026, [Online]. Available: https://izlik.org/JA66CZ85NZ
ISNAD
Adil, Mir Muhammad. “CRISPR/Cas12a-Based/Biosensors/for/Rapid/Detection/of/Carbapenem/Resistance/Genes:/Recent/Advances/and/Point-of-Care/Prospects”. Turkish Journal of Sensors and Biosensors. 2026-1 (November 15, 2026): 1-12. https://izlik.org/JA66CZ85NZ.
JAMA
1.Adil MM. CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects. Turkish Journal of Sensors and Biosensors. 2026;:1–12.
MLA
Adil, Mir Muhammad. “CRISPR/Cas12a-Based/Biosensors/for/Rapid/Detection/of/Carbapenem/Resistance/Genes:/Recent/Advances/and/Point-of-Care/Prospects”. Turkish Journal of Sensors and Biosensors, no. 2026-1, Nov. 2026, pp. 1-12, https://izlik.org/JA66CZ85NZ.
Vancouver
1.Mir Muhammad Adil. CRISPR/Cas12a-Based Biosensors for Rapid Detection of Carbapenem Resistance Genes: Recent Advances and Point-of-Care Prospects. Turkish Journal of Sensors and Biosensors [Internet]. 2026 Nov. 15;(2026-1):1-12. Available from: https://izlik.org/JA66CZ85NZ